Literature DB >> 30848739

[Features of community-acquired pneumonia in immunocompetent hospitalized adults according to the causal agent].

Fernando Saldias Peñafiel1, Javiera Gassmann Poniachik2, Alejandro Canelo López2, Orlando Díaz Patiño1.   

Abstract

BACKGROUND: Molecular biological techniques allow the identification of more pathogens associated with community-acquired pneumonia (CAP). AIM: To compare clinical and laboratory parameters of patients with CAP caused by different groups of pathogens.
MATERIAL AND METHODS: In a prospective study, immunocompetent adult patients hospitalized with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, polymerase chain reaction, urinary antigen testing and serology.
RESULTS: Pathogens were detected in 367 of 935 patients with CAP (39.2%). Streptococcus pneumoniae (10.7%) and influenza virus (6%) were the most frequently identified bacterial and viral pathogens, respectively. Pneumococcal pneumonia predominated in older adults, with multiple comorbidities, with elevation of inflammatory parameters and hypoxemia, like other bacterial pneumonias. Viral pneumonia predominated in elderly patients with multiple comorbidities, with a shorter hospital length of stay and lower mortality. Pneumonia associated with atypical microorganisms predominated in young adults, smokers, with subacute clinical evolution. Their hospital stays and lethality was similar to other bacterial pneumonias. Viral and classical bacterial pneumonias predominated in high risk pneumonia severity index categories. Although several variables were associated with the detection of a pathogen group, substantial overlap avoided the identification of reliable clinical predictors to distinguish etiologies.
CONCLUSIONS: The clinical and radiographic characteristics were similar in pulmonary infections caused by classical bacteria, respiratory viruses and atypical microorganisms. Therefore, microbial testing for common respiratory pathogens is still necessary to optimize treatment.

Entities:  

Mesh:

Year:  2018        PMID: 30848739     DOI: 10.4067/s0034-98872018001201371

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

Review 1.  Empiric Antibiotics in COVID 19: A Narrative Review.

Authors:  Elvina C Lingas
Journal:  Cureus       Date:  2022-06-02

2.  ARHGAP24 ameliorates inflammatory response through inactivating Rac1/Akt/NF-κB pathway in acute pneumonia model of rat.

Authors:  Huailian Liu; Wangpeng Wang; Wenyi Shen; Lili Wang; Yangsong Zuo
Journal:  Ann Transl Med       Date:  2020-10

3.  Risk of community-acquired pneumonia requiring hospitalization in patients with spondyloarthritis.

Authors:  Ho Yin Chung; Lai Shan Tam; Shirley Chiu Wai Chan; Jason Pui Yin Cheung; Pui Yan Wong; Chu Oi Ciang; Hoi Yan Ng; Mei Yan Law; Tin Lok Lai; Ching Han Wong
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-13       Impact factor: 5.346

4.  Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.

Authors:  Mentor Ali Ber Lucien; Michael F Canarie; Paul E Kilgore; Gladzdin Jean-Denis; Natael Fénélon; Manise Pierre; Mauricio Cerpa; Gerard A Joseph; Gina Maki; Marcus J Zervos; Patrick Dely; Jacques Boncy; Hatim Sati; Ana Del Rio; Pilar Ramon-Pardo
Journal:  Int J Infect Dis       Date:  2021-01-09       Impact factor: 3.623

5.  Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens.

Authors:  Rut Del Valle; Álvaro Ballesteros; Cristina Calvo; Talía Sainz; Ana Mendez; Carlos Grasa; Paula R Molina; María J Mellado; Francisco J Sanz-Santaeufemia; Blanca Herrero; Lourdes Calleja; Antoni Soriano-Arandes; Susana Melendo; Elena Rincón-López; Alicia Hernánz; Cristina Epalza; Carmen García-Baeza; E Rupérez-García; Arantxa Berzosa; Angustias Ocaña; Alvaro Villarroya-Villalba; Ana Barrios; Enrique Otheo; Juan C Galán; Mario José Rodríguez; Juan M Mesa; Sara Domínguez-Rodríguez; Cinta Moraleda; Alfredo Tagarro
Journal:  Pediatr Pulmonol       Date:  2022-07-08

6.  PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic.

Authors:  María Heredia-Rodríguez; Sara Balbás-Álvarez; Mario Lorenzo-López; Estefanía Gómez-Pequera; Pablo Jorge-Monjas; Silvia Rojo-Rello; Laura Sánchez-De Prada; Ivan Sanz-Muñoz; José María Eiros; Pedro Martínez-Paz; Hugo Gonzalo-Benito; Álvaro Tamayo-Velasco; Marta Martín-Fernández; Pilar Sánchez-Conde; Eduardo Tamayo; Esther Gómez-Sánchez
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.